Literature DB >> 28139846

Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome.

Y A Zarate1, L Kalsner2, A Basinger3, J R Jones4, C Li5, M Szybowska5, Z L Xu6, S Vergano7, A R Caffrey8, C V Gonzalez9, H Dubbs10, E Zackai10, F Millan11, A Telegrafi11, B Baskin11, R Person11, J L Fish12, D B Everman4.   

Abstract

SATB2-associated syndrome (SAS) is a multisystemic disorder caused by alterations of the SATB2 gene. We describe the phenotype and genotype of 12 individuals with 10 unique (de novo in 11 of 11 tested) pathogenic variants (1 splice site, 5 frameshift, 3 nonsense, and 2 missense) in SATB2 and review all cases reported in the published literature caused by point alterations thus far. In the cohort here described, developmental delay (DD) with severe speech compromise, facial dysmorphism, and dental anomalies were present in all cases. We also present the third case of tibial bowing in an individual who, just as in the previous 2 individuals in the literature, also had a truncating pathogenic variant of SATB2. We explore early genotype-phenotype correlations and reaffirm the main clinical features of this recognizable syndrome: universal DD with severe speech impediment, mild facial dysmorphism, and high frequency of craniofacial anomalies, behavioral issues, and brain neuroradiographic changes. As the recently proposed surveillance guidelines for individuals with SAS are adopted by providers, further delineation of the frequency and impact of other phenotypic traits will become available. Similarly, as new cases of SAS are identified, further exploration of genotype-phenotype correlations will be possible.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SATB2; cleft palate; tibial bowing; whole-exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28139846     DOI: 10.1111/cge.12982

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Dental radiographic findings in 18 individuals with SATB2-associated syndrome.

Authors:  John Scott; Chad Adams; Kirt Simmons; Andrea Feather; John Jones; Larry Hartzell; Lucia Wesley; Adam Johnson; Jennifer Fish; Katherine Bosanko; Stephen Beetstra; Yuri A Zarate
Journal:  Clin Oral Investig       Date:  2018-10-12       Impact factor: 3.573

2.  The Epilepsy Genetics Initiative: Systematic reanalysis of diagnostic exomes increases yield.

Authors: 
Journal:  Epilepsia       Date:  2019-04-05       Impact factor: 5.864

3.  Genes encoding SATB2-interacting proteins in adult cerebral cortex contribute to human cognitive ability.

Authors:  Isabella Cera; Laura Whitton; Gary Donohoe; Derek W Morris; Georg Dechant; Galina Apostolova
Journal:  PLoS Genet       Date:  2019-02-06       Impact factor: 5.917

4.  Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development.

Authors:  Matías Alvarez-Saavedra; Keqin Yan; Yves De Repentigny; Lukas E Hashem; Nidhi Chaudary; Shihab Sarwar; Doo Yang; Ilya Ioshikhes; Rashmi Kothary; Teruyoshi Hirayama; Takeshi Yagi; David J Picketts
Journal:  Front Mol Neurosci       Date:  2019-10-17       Impact factor: 5.639

5.  The behavioural phenotype of SATB2-associated syndrome: a within-group and cross-syndrome analysis.

Authors:  Stacey Bissell; Chris Oliver; Joanna Moss; Mary Heald; Jane Waite; Hayley Crawford; Vishakha Kothari; Lauren Rumbellow; Grace Walters; Caroline Richards
Journal:  J Neurodev Disord       Date:  2022-03-29       Impact factor: 4.025

6.  Atypical Peripheral Ossifying Fibroma of the Mandible.

Authors:  Tomislav Katanec; Lea Budak; Davor Brajdić; Dragana Gabrić
Journal:  Dent J (Basel)       Date:  2022-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.